Sinusoidal lining cells and hepatotoxicity

Toxicologic Pathology

Volumn 24, Issue 1, 1996, Pages 112-118

  Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

cytokines; Liver; nitric oxide; reactive oxygen intermediates

Indexed keywords

CARBON TETRACHLORIDE; ENDOTOXIN; GALACTOSAMINE; PARACETAMOL; PHENOBARBITAL;

CONFERENCE PAPER; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; LIVER SINUSOID; LIVER TOXICITY; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STELLATE CELL;

EID: 0030062401     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339602400115     Document Type: Conference Paper

References (118)

1. Abril ER, Simm WE, and Earnest DL (1989). Kupffer cell secretion of cytotoxic cytokines is enhanced by hypervitaminosis A. In: Cells of the Hepatic Sinusoid, Vol. 2, E Wisse, DL Knook, and K Decker (eds). The Kupffer Cell Foundation, Amsterdam, pp. 73-75.
2. Al-Tuwaijri A, Akdamar K, and DiLuzio NR (1981). Modification of galactosamine-induced liver injury in rats by reticuloendothelial system stimulation or depression. Hepatology 1: 107-113.
3. Arthur MJP, Bentley IS, Tanner AR, Saunders PK, Millward-Sadler GM, and Wright R (1985). Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology 89: 1114-1122.
4. Babior BM (1984). Oxidants from phagocytes: Agents of defense and destruction. Blood 64: 959-966.
5. Beckman JS (1991). The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 15: 53-59.
6. Beckman JS and Crow JP (1993). Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21: 330-334.
7. Beutler B and Cerami A (1987). Cachectin: More than a tumor necrosis factor. N. Engl. J. Med. 316: 379-385.
8. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J. Leukocyte Biol. 48: 565-569.
9. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, and Simmons RL (1989). An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J. Exp. Med. 169: 1467-1472.
10. Black HS (1989). Role of reactive oxygen species in inflammatory processes. In: Nonsteroidal Anti-Inflammatory Drugs. Pharmacology and the Skin, Vol. 2, C Hensby and NJ Lowe (eds). Basel-Karger, Basel, pp. 1-20.
11. Blomhoff R and Wake K (1991). Perisinusoidal stellate cells of the liver: Important roles in retinol metabolism and fibrosis. FASEB J. 5: 271-277.
12. Bouwens L, Baekeland M, De Zanger R, and Wisse E (1986). Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 6: 718-722,
13. 4. Br. J. Clin. Pharmacol. 17: 610-611.
14. Chojkier M and Fierer S (1985). D-galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. Gastroenterology 88: 115-121.
15. Cotran RS (1987). New roles for the endothelium in inflammation and immunity. Am. J. Pathol. 129: 407-413.
16. Darlington GJ, Wilson DR, Revel M, and Kelly JH (1989). Response of liver genes to acute phase mediators. Ann. N.Y. Acad. Sci. 557: 310-316.
17. Decker K (1990). Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192: 245-261.
18. De Leeuw AM, Praaning-Van Dalen DP, Brouwer A, and Knook DL (1989). Endocytosis in liver sinusoidal endothelial cells. In: Cells of the Hepatic Sinusoid, Vol. 2, E Wisse, DL Knook, and K Decker (eds). The Kupffer Cell Foundation, Amsterdam, pp. 94-98.
19. DelMaestro RF, Thaw H, Bjork J, Planker M, and Arfors KE (1980). Free radicals as mediators of tissue injury. Acta Physiol. Scand. (Suppl) 492: 43-57.
20. Dinarello CA (1989). Interleukin-1 and its related cytokines. In: Macrophage-Derived Cell Regulatory Factors. Cytokines, Vol. 1, C Sorg (ed). Basel-Karger, Basel, pp. 105-154.
21. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA Jr, and O'Connor JV (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163: 1433-1450.
22. Earnst DL, Brouwer A, Sim W, Horan MA, Hendriks HF, de Leeuw AM, and Knook DL (1986). Hypervitaminosis A activates Kupffer cells and lowers the threshold for endotoxin liver injury. In: Cells of the Hepatic Sinusoid, Vol. 1, A Kirn, DL Knook, and E Wisse (eds). The Kupffer Cell Foundation, Rijswijk, pp. 277-283.
23. Edwards MJ, Keller BJ, Kauffman FC, and Thurman RG (1993). The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol. Appl. Pharmacol. 119: 275-279.
24. ElSisi AE, Earnest DL, and Sipes IG (1993). Vitamin A potentiation of carbon tetrachloride hepatotoxicity: role of liver macrophages and active oxygen species. Toxicol. Appl. Pharmacol. 119: 295-301.
25. Eyhorn S, Schlayer HJ, Henninger HP, Dieter P, Hermann R, Woort-Menker M, Becker H, Schaefer H, and Decker K (1988). Rat hepatic sinusoidal endothelial cells in monolayer culture. Biochemical and ultrastructural characteristics. J. Hepatol. 6: 23-35.
26. Fantone JC and Ward PA (1982). Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol 107: 397-418.
27. Ferluga J and Allison A (1978). Role of mononuclear infiltrating cells in the pathogenesis of hepatitis. Lancet 2: 610-611.
28. Feder LS, and Laskin DL (1994). Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF and IL-1β following acute endotoxemia. J. Leukocyte Biol. 55: 507-513.
29. Feder LS, Todaro JA, and Laskin DL (1993). Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J. Leukocyte Biol. 53: 126-132.
30. Frederick J, Hasselgren P, Davis S, Higashiguchi T, and Fischer J (1993). Nitric oxide upregulates in vivo hepatic protein synthesis during endotoxemia. Arch. Surg. 128: 152-157.
31. Freudenberg MA, Keppler D, and Galanos C (1986). Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 51: 891-895.
32. Friedman SL, Roll FJ, Boyles J, and Bissell DM (1985). Hepatic lipocytes: The principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. USA 82: 8681-8685.
33. Gagnon L, Filion LG, Dubois C, and Rola-Pleszczynski R (1989). Leukotrienes and macrophage activation: augmented cytotoxic activity and enhanced interleukin 1, tumor necrosis factor and hydrogen peroxide production. Agents Actions 26: 141-147.
34. Galanos C, Freudenberg MA, and Reuter W (1979). Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76: 5939-5943.
35. Gardner CR, Barton D, Goller N, Durham S, and Laskin DL (1995). Role of tumor necrosis factor-α and nitric oxide in acetaminophen hepatotoxicity. The Toxicologist 15: 136 (abstract).
36. Gardner CR, Wasserman AJ, and Laskin DL (1987). Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res. 47. 6686-6691.
37. Ghezzo P, Saccardo B, and Bianchi M (1986). Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice. Biochem. Biophys. Res. Commun. 136: 316-321.
38. Goetzl E and Pickett W (1981). Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J. Exp Med. 153: 482-487.
39. Gunawardhana L, Mobley SA, and Sipes IG (1993). Modulation of 1,2-dichlorobenzene hepatotoxicity in the Fischer-344 rat by a scavenger of superoxide anions and an inhibitor of Kupffer cells. Toxicol. Appl. Pharmacol. 119: 205-213.
40. Hahn E, Wick G, Pencev D, and Timpl R (1980). Distribution of basement membrane protein in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut 21: 63-71.
41. Halliwell B and Gutteridge JMC (1984). Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219: 1-14.
42. Harbrecht B, Billiar T, Stadler J, Demetris A, Ochoa J, Curran R, and Simmons R (1992). Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J. Leukocyte Biol. 52: 390-394.
43. Heck DE, Laskin DL, Gardner CR, and Laskin JD (1992). Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role of nitric oxide in the regulation of wound healing. J. Biol. Chem. 267: 21277-21280.
44. Helyar L, Bundschuh DS, Laskin JD, and Laskin DL (1993). Hepatic fat storing cells produce nitric oxide and hydrogen peroxide in response to bacterially-derived lipopolysaccharide. In. Cells of the Hepatic Sinusoid, Vol. 3, DL Knook and K Decker (eds). The Kupffer Cell Foundation, Amsterdam, pp. 394-396.
45. Helyar L, Bundschuh DS, Laskin JD, and Laskin DL (1994). Induction of hepatic Ito cell nitric oxide production by acute endotoxemia. Hepatology 12: 1509-1515.
46. Hendriks HFJ, Horan MA, Durham SK, Earnest DL, Brouwer A, and Knook DL (1987). Endotoxin induced liver injury in aged and subacutely hypervitaminotic rats. Mech. Ageing Dev. 41: 241-249.
47. Hendriks HFJ, Verhoofstad WAMM, Brower A, and Knook DL (1985). Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver. Exp. Cell. Res. 160: 138-149.
48. Henson PM and Johnston RB (1987). Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J. Clin. Invest. 79: 669-674.
49. Hirano T (1992). Interleukin-6 and its relation to inflammation and disease. Clin. Immunol. Immunopathol. 62: S60-S65.
50. Hishinuma I, Nagakawa J, Hirota K, Mityamoto K, Tsukidate K, Yamanaka T, Katayama K, and Yamatsu I (1990). Involvement of tumor necrosis factor-α in development of hepatic injury in galactosamine-sensitized mice. Hepatology 12: 1187-1191.
51. Husztik E, Lazar G, and Parducz A (1980). Electron microscopic study of Kupffer cell phagocytosis blockade induced by gadolinium chloride. Br. J. Exp. Pathol. 61: 624-630.
52. Jirik FR, Podor TJ, Hirano T, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, and Lotz M. (1989). Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142: 144-147.
53. Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, and Brodie BB (1973). Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Therapeut. 187: 195-202.
54. Kayama F, Yoshida T, Elwell MR, and Luster MI (1995). Role of tumor necrosis factor-alpha in cadmium induced hepatotoxicity. Toxicol. Appl. Pharmacol. 131: 224-234.
55. Keppler D, Hagmann W, Rapp, R, Denzlinger C, and Koch HK (1985). The relation of leukotrienes to liver injury. Hepatology 5: 883-891.
56. G-methyl-1-arginine, an inhibitor of nitric oxide synthase. Biochem. Biophys. Res. Commun. 172: 1132-1138.
57. Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, and Waltersdorph AM (1986). Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136: 4220-4225.
58. Knook DL and Sleyster ECh (1980). Isolated parenchymal, Kupffer and endothelial rat liver cells characterized by their lysosomal enzyme content. Biochem. Biophys. Res. Commun. 96: 250-257.
59. Larrick JW and Wright SC (1990). Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 4: 3215-3223.
60. Laskin DL (1990). Nonparenchymal cells and hepatotoxicity. Semin. Liver Dis. 10: 293-304.
61. Laskin DL, Gardner CR, Maurer JK, and Driscoll KE (1993). Kupffer cell (KC)-derived tumor necrosis factor-alpha (TNF) as a mediator of hepatotoxicity. The Toxicologist 13: 427 (abstract).
62. Laskin DL, Gardner CR, Price V, and Jollow DJ (1995). Inhibition of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21: 1045-1050.
63. Laskin DL, Heck DE, Gardner CR, Feder LS, and Laskin JD (1995). Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute endotoxemia. J. Leukocyte Biol. 56: 751-758.
64. Laskin DL and Pendino KJ (1995). Macrophages and inflammatory mediators in tissue injury. In: Annual Review of Pharmacology & Toxicology, Vol. 35, A Cho, T Blaschke, H Loh, and JL Way (eds). Annual Review, Palo Alto, CA, pp. 655-677.
65. Laskin DL and Pilaro AM (1986). Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol. Appl. Pharmacol. 86: 204-215.
66. Laskin DL and Pilaro AM (1988) Activation of liver macrophages for killing of hepatocytes following acetaminophen treatment of rats. The Toxicologist 8: 32 (abstract).
67. Laskin DL, Pilaro AM, and Ji S (1986). Potential role of activated macrophages in acetaminophen hepatotoxicity. II. Mechanism of macrophage accumulation and activation. Toxicol. Appl. Pharmacol. 86: 216-226.
68. Laskin DL, Robertson FM, Pilaro AM, and Laskin JD (1988). Activation of liver macrophages following phenobarbital treatment of rats. Hepatology 8: 1051-1055.
69. Laskin DL, Rodriguez del Valle, M, Heck DE, Hwang S, Ohnishi ST, Durham SK, and Laskin JD (1995). Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. Hepatology 22: 223-234.
70. Lavnikova N and Laskin DL (1995) Unique patterns of regulation of nitric oxide production in fibroblasts. J. Leukocyte Biol. 58: 451-458.
71. Lehman V, Freudenberg MA, and Galanos C (1987). Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165: 657-663.
72. Liu P, McGuire GM, Fisher MA, Farhood A, Smith CW, and Jaeschke H (1995). Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 3: 56-62.
73. Lloyd RS and Triger DR (1975). Studies on hepatic uptake of antigen. III. Studies of liver macrophage function in normal rats and following carbon tetrachloride administration. Immunology 29: 253-263.
74. MacDonald JR, Beckstead JH, and Smuckler EA (1987). An ultrastructural and histochemical study of the prominent inflammatory response in D(+)-galactosamine hepatotoxicity. Br. J. Exp. Pathol. 68: 189-199.
75. Mathison JC and Ulevitch RJ (1979). The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J. Immunol. 123: 2133-2143.
76. Matsushima K and Oppenheim J (1989). Interleukin-8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1: 2-13.
77. McClain CJ and Cohen DA (1989). Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9: 497-499.
78. McCloskey TW, Todaro JA, and Laskin DL (1992). Effects of lipopolysaccharide treatment of rats on hepatic macrophage and endothelial cell antigen expression and oxidative metabolism. Hepatology 16: 191-203.
79. McCord JM (1974). Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase. Science 185: 529-531.
80. Moncada S, Palmer R, and Higgs E (1991). Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109-142.
81. Munkee R, Gasson J, Ogawa M, and Koeffler HP (1986). Recombinant TNF induces production of granulocyte-monocyte colony stimulating factor. Nature (London) 323: 79-82.
82. Nolan JP (1981). Endotoxin, reticuloendothelial function and liver injury. Hepatology 1: 458-465.
83. Nolan JP and Leibowitz AZ (1978). Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin B, an antiendotoxin. Gastroenterology 75: 445-449.
84. Onozaki K, Matsushima K, Kleinerman ES, Saito T, and Oppenheim JJ (1985). The role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity. J. Immunol. 135: 314-320.
85. Ooi BS, MacCarthy EP, Hsu A, and Ooi YM (1983). Human mononuclear cell modulation of endothelial cell proliferation. J. lab. Clin. Med. 102: 428-433.
86. Oppenheim JI, Kovacs EJ, Matsushima K, and Durum SK (1986). There is more than one interleukin 1. Immunol. Today 7: 45-56.
87. Perlmutter DH, Dinarello CA, Punsal PI, and Colten HR (1986). Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J. Clin Invest. 78: 1349-1354.
88. Pilaro AM and Laskin DL (1986). Accumulation of activated mononuclear phagocytes in the liver following lipopolysaccharide treatment of rats. J. Leukocyte Biol. 40: 29-41.
89. Pinzani M, Abboud HE, Gesualdo L, and Abboud SL (1992). Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. Am. J. Physiol. 262: C876-C881.
90. Przybocki J, Reuhl K, Thurman R, and Kauffman F (1992). Involvement of nonparenchymal cells in oxygen-dependent hepatic injury by allyl alcohol. Toxicol. Appl. Pharmacol. 119: 295-301.
91. Punjabi C, Laskin DL, Heck DE, and Laskin JD (1992). Production of nitric oxide by bone marrow cells: Inverse correlation with proliferation. J. Immunol. 149: 2179-2184.
92. Ramadori G (1991). The stellate cell (Ito cell, fat storing cell, lipocyte, perisinusoidal cell) of the liver. Virchows Arch. B Cell Pathol. 61: 147-158.
93. Rogoff TM and Lipsky PE (1980). Antigen presentation by isolated guinea pig Kupffer cells. J. Immunol. 124: 1740-1744.
94. Rubin R and Farber JL (1984). Mechanisms of the killing of cultured hepatocytes by hydrogen peroxide. Arch. Biochem. Biophys. 228: 450-459.
95. Sacks T, Malt CF, Craddock PR, Bowers TK, and Jacob HS (1977). Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J. Clin. Invest. 61: 1161-1167.
96. Sato N, Goto T, and Haranaki K (1986). Actions of tumor necrosis factor on cultured vascular endothelial cells: Morphologic modulation, growth inhibition, and cytotoxicity. J. Natl. cancer Inst. 76: 1113-1121.
97. Sevanian A and Hochstein P (1985). Mechanisms and consequences of lipid peroxidation in biological systems. Annu. Rev. Nutr. 5: 365-390.
98. Shedlofsky SI and McClain CJ (1991). Hepatic dysfunction due to cytokines. In: Cytokines and Inflammation, ES Kimball (ed). CRC Press, Boca Raton, FL, pp. 235-273.
99. Shiratori Y, Kawase T, Shiina S, Okano K, Sugimoto T, Teraoka H, Matano S, Matsumoto K, and Kamii K (1988). Modulation of hepatotoxicity by macrophages in the liver. Hepatology 8: 815-821.
100. Shiratori Y, Takikawa H, Kawase T, and Sugimoto T (1986) Superoxide anion generating capacity and lysosomal enzyme activities of Kupffer cells in galactosamine-induced hepatitis. Gastroenterol. Jpn. 21: 135-144.
101. Shiratori Y, Tanaka M, Hai K, Kawase T, Shiina S, and Sugimoto T (1990). Role of endotoxin-responsive macrophages in hepatic injury. Hepatology 11: 183-192.
102. Shiratori Y, Tanaka M, Umihara J, Kawase T, Shiina S, and Sugimoto T (1990). Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophages. J. Hepatol. 10: 51-61.
103. Silva AT, Bayston KF, and Cohen J (1990). Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-α in experimental gram-negative shock. J. Infect. Dis. 162: 421-427.
104. Sim WW, Abril ER, and Earnest DL (1989). Mechanisms of Kupffer cell activation in hypervitaminosis A. In: Cells of the Hepatic Sinusoid, Vol. 2, E. Wisse, DL Knook, and K Decker (eds). The Kupffer Cell Foundation, Amsterdam, pp. 91-93.
105. Smedstod B, Pertoft H, Eggertsen G, and Sundstrom C (1985). Functional and morphological characterization of cultures of Kupffer cells and liver endothelial cell prepared by means of density separation in percoll, and selective substrate adherence. Cell Tissue Res. 241: 639-649.
106. Souhami RL and Bradfield JW (1981). The recovery of hepatic phagocytosis after blockade of Kupffer cells. J. Reticuloendothel. Soc. 16: 75-86.
107. Stark ME and Szurszewski JH (1992). Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103: 1928-1949.
108. Stuehr DJ and Nathan CF (1989). Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in rumor target cells. J. Exp. Med. 169: 1543-1555.
109. 4 induced hepatotoxicity in rats. Indian J. Physiol. Pharmacol. 36: 127-129.
110. Sugino K, Dohi K, Yamada K, and Kawasaki T (1989). Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants. Surgery 105: 200-206.
111. Tanner A, Keyhani A, Reiner R, Holdstock G, and Wright R (1980). Proteolytic enzymes released by liver macrophages may promote hepatic injury in a rat model of hepatic damage. Gastroenterology 80: 647-654.
112. Thompson WD, Jack AS, and Patrick RS (1980). The possible role of macrophages in transient hepatic fibrogenesis induced by acute carbon tetrachloride injury. J. Pathol. 130: 65-73.
113. Tiegs G and Wendel A (1988). Leukotriene-mediated liver injury. Biochem. Pharmacol. 37: 2569-2573.
114. Tiegs G, Wolter M, and Wendel A (1989). Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 38: 627-631.
115. Tiku ML and Tomasi TB (1985). Enhancement of endothelial plasminogen activator synthesis by lymphokines. Transplantation 40: 293-298.
116. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert J, Shires GT, and Cerami A (1986). Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474.
117. Whicher JT and Evans SW (1990). Cytokines in disease. Clin. Chem. 36/7: 1269-1281.
118. Wisse E and Knook DL (1979). The investigation of sinusoidal cells: A new approach to the study of liver function. Prog. Liver Dis. 6: 153-171.